Open Access

Discussion.

Topic: Lipid-Lowering Agents
Organised by PACE-CME, supported by Amarin in the form of an educational grant

Presentation

About the speaker

Professor Peter Libby

Brigham and Women's Hospital, Boston (United States of America)
28 presentations
2 followers

4 more presentations in this session

Introduction.

Speaker: Professor P. Libby (Boston, US)

Thumbnail

The residual risk challenge in CVD: How important are triglycerides?

Speaker: Professor U. Landmesser (Berlin, DE)

Thumbnail

Non-LDL in CV risk management & guidelines: What are the opportunities?

Speaker: Professor K. Ray (London, GB)

Thumbnail

Lessons from REDUCE-IT: How will the results impact practice?

Speaker: Professor D. Bhatt (Boston, US)

Thumbnail

Access the full session

Novel opportunities tackling residual cardiovascular Risk: The evolving role of triglycerides

Speakers: Professor P. Libby, Professor P. Libby, Professor U. Landmesser, Professor K. Ray, Professor D. Bhatt
Thumbnail

About the event

Image

ESC CONGRESS 2020 - The Digital Experience

28 August - 1 September 2020

Sessions Presentations

Related content

Open Access

Classification of HF and diagnosis and treatment of HFmrEF and HFpEF.

27 August 2021

Open Access

Panel Discussion: The case for combination therapy: The way forward in intensive LDL-c management?

27 August 2021

Open Access

LDL-c in the management of high CV risk: Changing the paradigm for prevention.

27 August 2021

This platform is supported by

logo Novo Nordisk